Trial name: Danish on-farm trials with Cabanin® CSD in dairy cows (vitamin E replacement strategy + protein optimisation)
Year: 2021 (with a long-term farm update through 2023)
Country / partners: Denmark — commercial dairy farms (Louiselund; Hedsgård & Mindegård) in collaboration with R2 Agro
Duration: 150 days from peak lactation
These Danish on-farm trials were designed to validate Cabanin® CSD as a vitamin E replacer in dairy cow rations—with results you can use in real feeding programs. Beyond the intended antioxidant strategy, the trials pointed to an extra lever: improved protein utilisation efficiency, opening the door to protein optimisation without compromising output.
The trial material includes two commercial setups in Denmark (2021), plus a long-term update showing continued use on-farm through 2023.
Results
- Farm test I (Louiselund, Denmark): 1,000 mg Cabanin® CSD per cow/day was used to replace 400 IU natural vitamin E (RRR alpha-tocopherol) as part of the farm’s vitamin E strategy.
- Protein optimisation signal (Louiselund): milk urea increased after introducing Cabanin®, and crude protein was adjusted from 17.0% → 16.5% per kg DM to reach target milk urea levels (4.0 mmol/L).
- Long-term adoption (Louiselund): an update states that after more than 2 years, the farm still uses Cabanin® CSD as a 50% vitamin E replacement with the same 1,000 mg/day strategy replacing 400 IU natural RRR vitamin E.
- Farm test II (Hedsgård & Mindegård, Denmark): the test group received 5 g Cabanin® CSD per cow/day and the ration removed 0.2 kg soybean meal (SBM); cows on Cabanin had consistently higher milk yield during the trial on a lower protein diet.
Conclusion
These Danish farm trials support Cabanin® CSD as a practical way to reduce reliance on vitamin E above minimum requirements, while also indicating a second advantage: protein optimisation (lower crude protein / less SBM) without sacrificing milk yield in the documented test periods.
